Accelerate DiagnosticsAXDXQ
13F holders, Q2 2025 (June 30)2holders −40
0new positions
41sold out
$0.00avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Accelerate Diagnostics Inc. (AXDXQ) in their 13F filings, down 40 from Q1 2025. 0 opened new positions and 41 sold out. The largest holders were Bartlett & Co. Wealth Management LLC ($1) and Osaic Holdings, Inc. ($0).
- Company
- Accelerate Diagnostics Inc.
- CUSIP
- 00430H201
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 41 | $2.9M |
All 13F filers, Q1 2025 → Q2 2025: 4,105,299 shares sold, net −4,105,299 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Bartlett & Co. Wealth Management LLC | 0.00% | No change | 100 | $1 |
| Osaic Holdings, Inc. | 0.00% | No change | 889 | $0 |
"% of holder's portfolio" is AXDXQ's weight in each manager's 13F, not the share of Accelerate Diagnostics Inc. the manager owns.